Evidence map›Paper›PMID 22857835›Full record

ReviewPediatric clinics of North America2012

Urolithiasis in children: medical approach.

Lawrence Copelovitch

Registry-linked trialAbstract readReview
In one paragraph

Review in Pediatric clinics of North America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06138704 (Retrograde Intrarenal Surgery Results and Stone-free Rate in Children With Kidney Stones), which is not on this map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06138704 completednot on this mapstarted 2019, after this paper: background citation

Retrograde Intrarenal Surgery Results and Stone-free Rate in Children With Kidney Stones

Typeobservational_patient_registrySponsorAnkara City Hospital BilkentRan2019 to 2023Enrolled105ConditionsRenal Stone, Retrograde Intrarenal SurgeryArmsRetrograde Intrarenal Surgery
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. The use of alpha-1 adrenergic blockers in children with distal ureterolithiasis: a systematic review and meta-analysis.International braz j urol : official journal of the Brazilian Society of Urology
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Risk factors for recurrence in pediatric urinary stone disease.Pediatric nephrology (Berlin, Germany) · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Urinary stone disease in Syrian children.Pediatric nephrology (Berlin, Germany) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Lawrence CopelovitchDivision of Nephrology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Copelovitch@email.chop.edu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Childhood urolithiasis is an evolving condition with an increasing incidence and prevalence over the last 2 decades. Over that time the underlying cause has shifted from predominantly infectious to metabolic in nature. This review describes the pathophysiology, underlying metabolic abnormalities, clinical presentation, evaluation, and management of childhood urolithiasis. A comprehensive metabolic evaluation is essential for all children with renal calculi, given the high rate of recurrence and the importance of excluding inherited progressive conditions.

Indexed as

Calcium OxalateCalcium PhosphatesChildChild, PreschoolCitric AcidCystinuriaDiagnostic ImagingFemaleHumansHypercalciuriaHyperoxaluriaInfantInfant, NewbornMaleRisk FactorsUrinalysisCalcium Oxalatecalcium phosphateCalcium PhosphatesCitric Acid

Identifiers

PMID22857835
PMCPMC3426770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.